- Drug Pipelines
- April 2025
- 60 Pages
Global
From €891EUR$1,000USD£777GBP
€1113EUR$1,250USD£972GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €891EUR$1,000USD£777GBP
€1113EUR$1,250USD£972GBP
- Report
- June 2025
- 147 Pages
Global
From €4364EUR$4,900USD£3,808GBP
- Report
- November 2024
- 172 Pages
Global
From €3206EUR$3,600USD£2,798GBP
- Report
- June 2025
- 150 Pages
Global
From €2404EUR$2,699USD£2,098GBP
- Report
- June 2025
- 150 Pages
Global
From €2404EUR$2,699USD£2,098GBP
- Report
- June 2025
- 400 Pages
Global
From €4407EUR$4,949USD£3,846GBP
- Report
- June 2025
- 140 Pages
Global
From €3671EUR$4,123USD£3,204GBP
€4319EUR$4,850USD£3,769GBP
- Report
- July 2025
- 55 Pages
Asia Pacific
From €2894EUR$3,250USD£2,526GBP
- Report
- July 2025
- 60 Pages
Europe
From €2894EUR$3,250USD£2,526GBP
- Report
- November 2024
- 71 Pages
North America
From €1336EUR$1,500USD£1,166GBP
- Report
- November 2024
- 79 Pages
Africa, Middle East
From €1336EUR$1,500USD£1,166GBP
- Report
- November 2024
- 80 Pages
Europe
From €1336EUR$1,500USD£1,166GBP
- Report
- November 2024
- 80 Pages
Asia Pacific
From €1336EUR$1,500USD£1,166GBP
- Report
- June 2025
- 120 Pages
Global
From €5299EUR$5,950USD£4,624GBP
- Report
- October 2025
- 188 Pages
Global
From €3157EUR$3,545USD£2,755GBP
€3508EUR$3,939USD£3,061GBP
- Report
- October 2025
- 190 Pages
Global
From €3157EUR$3,545USD£2,755GBP
€3508EUR$3,939USD£3,061GBP
- Report
- October 2025
- 186 Pages
Global
From €3157EUR$3,545USD£2,755GBP
€3508EUR$3,939USD£3,061GBP
- Report
- August 2025
- 189 Pages
Global
From €3157EUR$3,545USD£2,755GBP
€3508EUR$3,939USD£3,061GBP
- Report
- August 2025
- 193 Pages
Global
From €3157EUR$3,545USD£2,755GBP
€3508EUR$3,939USD£3,061GBP

The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates.
Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more